Oddvar Solli

595 total citations
10 papers, 456 citations indexed

About

Oddvar Solli is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Oddvar Solli has authored 10 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Epidemiology, 3 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Oddvar Solli's work include Renal cell carcinoma treatment (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Diabetes Management and Education (2 papers). Oddvar Solli is often cited by papers focused on Renal cell carcinoma treatment (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Diabetes Management and Education (2 papers). Oddvar Solli collaborates with scholars based in Norway, Sweden and Denmark. Oddvar Solli's co-authors include Knut Stavem, IS Kristiansen, Waleed Ghanima, Christian Jonasson, Ingunn Fride Tvete, Pål Falck, Sigrun Halvorsen, Ivar S. Kristiansen, Trond Jenssen and Ulrika Axcrona and has published in prestigious journals such as Annals of the Rheumatic Diseases, Health and Quality of Life Outcomes and OncoTargets and Therapy.

In The Last Decade

Oddvar Solli

8 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oddvar Solli Norway 5 203 143 109 107 50 10 456
Eva Lesén Sweden 12 69 0.3× 55 0.4× 62 0.6× 95 0.9× 12 0.2× 43 356
Hélène Derumeaux France 10 74 0.4× 44 0.3× 54 0.5× 23 0.2× 18 0.4× 22 404
Edmund J. Pezalla United States 10 54 0.3× 45 0.3× 141 1.3× 171 1.6× 77 1.5× 25 527
Eva Fhärm Sweden 12 100 0.5× 60 0.4× 25 0.2× 138 1.3× 17 0.3× 19 414
José Francisco Kerr Saraiva Brazil 13 238 1.2× 39 0.3× 24 0.2× 234 2.2× 10 0.2× 46 581
Martha Emneus Denmark 10 156 0.8× 108 0.8× 38 0.3× 50 0.5× 8 0.2× 20 383
Yolanda Martinez United Kingdom 10 125 0.6× 47 0.3× 33 0.3× 65 0.6× 10 0.2× 15 308
Anna Ringborg Sweden 10 152 0.7× 70 0.5× 85 0.8× 218 2.0× 15 0.3× 13 479
Koo Wilson Sweden 14 23 0.1× 70 0.5× 153 1.4× 75 0.7× 22 0.4× 44 547
J. del Llano Spain 6 32 0.2× 62 0.4× 116 1.1× 54 0.5× 11 0.2× 9 365

Countries citing papers authored by Oddvar Solli

Since Specialization
Citations

This map shows the geographic impact of Oddvar Solli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oddvar Solli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oddvar Solli more than expected).

Fields of papers citing papers by Oddvar Solli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oddvar Solli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oddvar Solli. The network helps show where Oddvar Solli may publish in the future.

Co-authorship network of co-authors of Oddvar Solli

This figure shows the co-authorship network connecting the top 25 collaborators of Oddvar Solli. A scholar is included among the top collaborators of Oddvar Solli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oddvar Solli. Oddvar Solli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Solli, Oddvar, et al.. (2025). Cost‐Effectiveness Analysis of a Maternal Vaccination Program Against Respiratory Syncytial Virus in Norway. Influenza and Other Respiratory Viruses. 19(9). e70161–e70161.
2.
Jonasson, Christian, Christian Beisland, Tom Børge Johannesen, et al.. (2025). Overall Survival of Patients with Metastatic Renal Cell Carcinoma Following the Introduction of Targeted and Immunotherapies: A Norwegian Retrospective, Real-World Registry Data Study (RECON3). Cancer Management and Research. Volume 17. 103–112. 1 indexed citations
3.
Solli, Oddvar, et al.. (2022). Nye metoder – blir pasienten hørt?. Tidsskrift for Den norske legeforening. 142(6).
5.
Aas, Eline, et al.. (2019). A cost-utility analysis of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction. The European Journal of Health Economics. 21(1). 73–84. 8 indexed citations
6.
Småstuen, Milada Cvancarova, et al.. (2019). OP0311 RETROSPECTIVE ANALYSIS OF PRESCRIPTION DYNAMICS OF ETANERCEPT AFTER INTRODUCTION OF BIOSIMILARS BASED ON NORWEGIAN PRESCRIPTION DATABASE. AN INTERIM ANALYSIS. Annals of the Rheumatic Diseases. 78. 237–238. 1 indexed citations
7.
Beisland, Christian, T.B. Johannesen, Olbjørn Klepp, et al.. (2017). Overall survival in renal cell carcinoma after introduction of targeted therapies: a Norwegian population-based study. OncoTargets and Therapy. Volume 10. 371–385. 27 indexed citations
8.
Halvorsen, Sigrun, Waleed Ghanima, Ingunn Fride Tvete, et al.. (2016). A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants. European Heart Journal - Cardiovascular Pharmacotherapy. 3(1). 28–36. 95 indexed citations
9.
Solli, Oddvar, Knut Stavem, & IS Kristiansen. (2010). Health-related quality of life in diabetes: The associations of complications with EQ-5D scores. Health and Quality of Life Outcomes. 8(1). 18–18. 293 indexed citations
10.
Solli, Oddvar, Trond Jenssen, & Ivar S. Kristiansen. (2010). Diabetes: cost of illness in Norway. BMC Endocrine Disorders. 10(1). 15–15. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026